Skip to main content
Log in

The Effect of PSD-93 Deficiency on the Expression of Early Inflammatory Cytokines Induced by Ischemic Brain Injury

  • Original Paper
  • Published:
Cell Biochemistry and Biophysics Aims and scope Submit manuscript

Abstract

The aim of the study was to explore the effect of PSD-93 deficiency on the expression of early inflammatory cytokines induced by cerebral ischemia/reperfusion injury. Ten- to twelve-week-old male PSD-93 knockout (PSD-93 KO) mice (C57BL/6 genetic background) and wild-type (WT) littermates were randomly divided into sham and ischemia/reperfusion (I/R) group. The focal cerebral I/R model was established by middle cerebral artery occlusion (MCAO) suture method. RT-PCR was used to detect the mRNA expression of IL-6, IL-10, Cox-2, iNOS, and TNF-α4h following reperfusion. Infarct volume at different time points after I/R was analyzed using 2,3,5-triphenyl tetrazolium staining, and neurological damage score (neurological severity scores, NSS) was used to evaluate the effect of PSD-93 gene knockout on the MCAO-induced neurological injury. In WT mice, early I/R injury led to the increase in the mRNA expression of proinflammatory cytokines IL-6, Cox-2, iNOS, and TNF-α that coincided with the decrease in the expression of anti-inflammatory cytokine IL-10, as compared to the sham group (P < 0.05). This effect was markedly attenuated by depleting PSD-93 levels by gene knockout. As compared to sham group, in PSD-93 KO mice I/R4h led to downregulation of Cox-2 and iNOS expression, and increase in the mRNA levels of IL-10 (P < 0.05). In addition, following MCAO, PSD-93 KO mice exhibited improved NSS and reduced infarct volumes, as compared with WT animals. PSD-93 knockout may play a neuroprotective role by mediating the early release of inflammatory cytokines induced by cerebral ischemia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Johnston, S. C., Mendis, S., & Mathers, C. D. (2009). Global variation in stroke burden and mortality: Estimates from monitoring, surveillance, and modeling. Lancet Neurology, 8, 345–354.

    Article  PubMed  Google Scholar 

  2. Choi, D. W. (1992). Excitotoxic cell death. Journal of Neurobiology, 23, 1261–1276.

    Article  CAS  PubMed  Google Scholar 

  3. Aarts, M., Liu, Y., Liu, L., et al. (2002). Treatment of ischemic brain damage by perturbing NMDA receptor–PSD-95 protein interactions. Science, 298, 846–850.

    Article  CAS  PubMed  Google Scholar 

  4. Xu, Y., Zhang, B., Hua, Z., et al. (2004). Targeted disruption of PSD-93 gene reduces platelet-activating factor-induced neurotoxicity in cultured cortical neurons. Experimental Neurology, 189(1), 16–24.

    Article  CAS  PubMed  Google Scholar 

  5. Zhang, M., Xu, J. T., Zhu, X., et al. (2010). Postsynaptic density-93 deficiency protects cultured cortical neurons from N-methyl-D-aspartate receptor-triggered neurotoxicity. Neuroscience, 166(4), 1083–1090.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  6. Zhang, M., Li, Q., Chen, L., et al. (2014). PSD-93 deletion inhibits Fyn-mediated phosphorylation of NR2B and protects against focal cerebral ischemia. Neurobiology of Diseases, 68, 104–111.

    Article  CAS  Google Scholar 

  7. Jia, J., Guan, D., Zhu, W., et al. (2009). Estrogen inhibits Fas-mediated apoptosis in experimental stroke. Experimental Neurology, 215(1), 48–52.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  8. Chen, J., Li, Y., Wang, L., et al. (2001). Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke, 32(4), 1005–1011.

    Article  CAS  PubMed  Google Scholar 

  9. Wang, L., Zhang, L., Chen, Z. B., et al. (2009). Icariin enhances neuronal survival after oxygen and glucose deprivation by increasing SIRT1. European Journal of Pharmacology, 609(1–3), 40–44.

    Article  CAS  PubMed  Google Scholar 

  10. Jones, N. (2011). Stroke: Disruption of the nNOS–PSD-95 complex is neuroprotective in models of cerebral ischemia. Nature Reviews Neurology, 7(2), 61.

    Article  PubMed  Google Scholar 

  11. Zhou, L., Li, F., Xu, H. B., et al. (2010). Treatment of cerebral ischemia by disrupting ischemia-induced interaction of nNOS with PSD-95. Nature Medicine, 16(12), 1439–1443.

    Article  CAS  PubMed  Google Scholar 

  12. Chen, Z. B., Huang, D. Q., Niu, F. N., et al. (2010). Human urinary kallidinogenase suppresses cerebral inflammation in experimental stroke and downregulates nuclear factor-kappaB. Journal of Cerebral Blood Flow and Metabolism, 30(7), 1356–1365.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  13. Niu, F., Zhang, X., Chang, L., et al. (2009). Trichostatin A enhances OGD-astrocyte viability by inhibiting inflammatory reaction mediated by NF-kappaB. Brain Research Bulletin, 78(6), 342–346.

    Article  CAS  PubMed  Google Scholar 

  14. Takenouchi, T., Sugama, S., Iwamaru, Y., et al. (2009). Modulation of the ATP-lnduced release and processing of IL-1 in microglial cells. Critical Reviews in Immunology, 29, 335–345.

    Article  CAS  PubMed  Google Scholar 

  15. Brough, D., Le Feuvre, R. A., Iwakura, Y., et al. (2002). Purinergic (P2X7) receptor activation of microglia induces cell death via an interleukin-1-independent mechanism. Molecular and Cellular Neuroscience, 19, 272–280.

    Article  CAS  PubMed  Google Scholar 

  16. Suzuki, T., Hide, I., Ido, K., et al. (2004). Production and release of neuroprotective tumor necrosis factor by P2X7 receptor-activated microglia. Journal of Neuroscience, 24, 1–7.

    Article  CAS  PubMed  Google Scholar 

  17. Anderson, C. M., Bergher, J. P., & Swanson, R. A. (2004). ATP-induced ATP release from astrocytes. Journal of Neurochemistry, 88, 246–256.

    Article  CAS  PubMed  Google Scholar 

  18. Butovsky, O., Jedrychowski, M. P., Moore, C. S., et al. (2014). Identification of a unique TGF-β-dependent molecular and functional signature in microglia. Nature Neuroscience, 17(1), 131–143.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  19. Sheridan, G. K., & Murphy, K. J. (2013). Neuron-glia crosstalk in health and disease: Fractalkine and CX3CR1 take centre stage. Open Biology, 3(12), 130181.

    Article  PubMed Central  PubMed  Google Scholar 

  20. Scianni, M., Antonilli, L., Chece, G., et al. (2013). Fractalkine (CX3CL1) enhances hippocampal N-methyl-D-aspartate receptor (NMDAR) function via d-serine and adenosine receptor type A2 (A2AR) activity. Journal of Neuroinflammation, 10, 108.

    Article  PubMed Central  PubMed  Google Scholar 

  21. Cipriani, R., Villa, P., Chece, G., et al. (2011). CX3CL1 is neuroprotective in permanent focal cerebral ischemia in rodents. Journal of Neuroscience, 31(45), 16327–16335.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We would like to thank Dr. Yuanxiang Tao for providing PSD-93 KO mice. This study was supported by the National Natural Science Foundation of China (81301120, 81200897), the Natural Science Foundation of the Colleges and Universities in Jiangsu Province (13KJB320027) and Xuzhou Medical Young Talents Project.

Conflict of interest

The authors declare no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Gang Hu or Yun Xu.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhang, Q., Cheng, H., Rong, R. et al. The Effect of PSD-93 Deficiency on the Expression of Early Inflammatory Cytokines Induced by Ischemic Brain Injury. Cell Biochem Biophys 73, 695–700 (2015). https://doi.org/10.1007/s12013-015-0666-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12013-015-0666-9

Keywords

Navigation